by American Society of Hematology Micrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Patients with multiple myeloma treated with idecabtagene vicleucel, known as “ide-cel,” a chimeric antigen receptor (CAR) T-cell therapy, had no difference in overall survival outcomes regardless of race and ethnicity, according to a study published in...
by American Society for Microbiology Credit: CC0 Public DomainAn estimated 40% of the global adult population have high blood pressure, or hypertension, which puts people at risk of cardiovascular disease and other dangerous health conditions. Recent studies suggest that probiotics may offer a protective effect, but researchers have a limited understanding of why shaping the gut...
by National University of Singapore A bandage pre-loaded with magnetic hydrogel is placed on the wound and an external device is used to accelerate the wound healing process. Credit: National University of SingaporeDiabetic patients whose natural wound-healing capabilities are compromised often develop chronic wounds that are slow to heal. Such non-healing wounds could cause serious infections...
by British Medical Journal Credit: CC0 Public DomainTwo widely used statins, rosuvastatin and atorvastatin, are equally effective at preventing heart attacks, strokes and death in people with coronary artery disease. But while rosuvastatin treatment is associated with lower cholesterol levels, it also carries a higher risk of developing type 2 diabetes than atorvastatin, finds a study...
Vibrant, is not a drug but a capsule that stimulates natural movements in the gut Its vibrations stimulate the colon to contract naturally to relieve constipation READ MORE: America suffering shortage of LAXATIVES due to surging demand By CAITLIN TILLEY, HEALTH REPORTER FOR DAILYMAIL.COM PUBLISHED: 11:48 EDT, 18 October 2023 | UPDATED: 11:56 EDT, 18 October 2023 An easy-to-swallow vibrating capsule that offers...
F. Perry Wilson, MD, MSCEDISCLOSURES October 17, 2023 Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr F. Perry Wilson of the Yale School of Medicine. Today I’m going to talk to you about a study at the cutting edge of modern medicine, one that uses an artificial intelligence model...
Sue Hughes October 16, 2023 The issue of earlier classification of medical conditions — known as “diagnosis creep” — is leading to many patients becoming eligible for treatments at earlier stages in their disease course, without those treatments having been validated in those particular groups. This concern has been highlighted recently in the atrial fibrillation (AF) field,...
Experts claim latest research from Harvard University adds a greater level of certainty about the link Andrew Gregory Health editor The chances of a person developing type 2 diabetes can increase even if they eat red meat just two times a week instead of an alternative option, researchers have said. Replacing red meat with plant-based protein...
by Lori Solomon Patients with hemophilia A or B with inhibitors have a lower annualized bleeding rate with concizumab than with no prophylaxis, according to a phase 3 study published online Aug. 31 in the New England Journal of Medicine. Tadashi Matsushita, M.D., Ph.D., from Nagoya University Hospital in Japan, and colleagues evaluated the safety...
by Viviana Sofía Flores Rivera, Yale University Credit: Pixabay/CC0 Public DomainLenacapavir, an injection, has been approved by the FDA for multi-drug resistant HIV. HIV is not curable yet, but it can be treated successfully throughout someone’s lifespan. “And so, in the field, we want to ensure that the treatments we have—which for now are for...
